Literature DB >> 9373160

Translational control of terminal oligopyrimidine mRNAs requires a specific regulator.

F Loreni1, F Amaldi.   

Abstract

Terminal oligopyrimidine (TOP) mRNAs are a group of messengers translationally regulated according to the growth status of the cell. Two hypotheses have been proposed for the mechanism of the regulation: (i) there is a specific translational regulator which can reversibly alter TOP-mRNA structure, (ii) a component of the general translational apparatus can specifically affect the translation of TOP-mRNAs. To verify one of the two hypotheses we induced a partial inhibition of translation initiation in Xenopus cultured cells and analyzed the effect on TOP-mRNA translation. Our results suggest that a specific regulator is necessary to explain the translational control of these of mRNAs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373160     DOI: 10.1016/s0014-5793(97)01209-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis.

Authors:  John C Kash; Dawn M Cunningham; Maria W Smit; Youngwoo Park; David Fritz; Jeffrey Wilusz; Michael G Katze
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

2.  p70(S6K) controls selective mRNA translation during oocyte maturation and early embryogenesis in Xenopus laevis.

Authors:  M S Schwab; S H Kim; N Terada; C Edfjäll; S C Kozma; G Thomas; J L Maller
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

3.  Ribosomal stress activates eEF2K-eEF2 pathway causing translation elongation inhibition and recruitment of terminal oligopyrimidine (TOP) mRNAs on polysomes.

Authors:  Angelo Gismondi; Sara Caldarola; Gaia Lisi; Giada Juli; Lidia Chellini; Valentina Iadevaia; Christopher G Proud; Fabrizio Loreni
Journal:  Nucleic Acids Res       Date:  2014-10-20       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.